首页> 外文会议>World biomaterials congress >Photochemical tussue penetration via photosensitizer for the efficient penetration of drug into tumor tissue
【24h】

Photochemical tussue penetration via photosensitizer for the efficient penetration of drug into tumor tissue

机译:通过光敏剂进行光化学刻痕渗透,以有效地将药物渗透到肿瘤组织中

获取原文

摘要

Introduction: A non-vascular drug eluting stent (DES) is a biomedical device that is implanted in the gastrointestinal (GI) tract for stabilizing the flow of body fluids when obstructive symptoms are shown due to tumor growth. Recently, gemcitabine (GEM) eluting membrane covered stents have been developed and highlighted because of the strong therapeutic effect of GEM in Gl tumor therapy. However, GEM has a low tissue penetration efficiency (PE%) in the Gl tract because of its hydrophilicity and the epithelial barrier function. For this reason, some cells of a GEM treated tumor can continue to proliferate and allow tumor growth. We believe that an alteration of the epithelial layer is required for improving drug penetration. Materials and Methods: To prepare the membranes, 200 mL of the above mixed solution(Gemcitabine(GEM), Photosensitizer(PS), Polyurethane(PU)) was poured into the polytetrafluorethylene (Teflon) mold and dried. The surface morphologies of each membrane were observed with Field emission-scanning electron microscopy (FE-SEM). To confirm the drug release behaviors, GEM-PU (PS absent membrane) and PS-GEM-PU were placed into conical tubes, and phosphate buffer saline was added. To confirm the generation of singlet oxygen, PS-GEM-PU was incubated in PBS for 0,1 or 2 weeks. To confirm the PE% enhancing mechanism, CT-26 cells were cultured in a 6-well plate and Chang cells were cultured . To visualize the tissue penetration of the hydrophilic molecule, fluorescein was loaded instead of GEM in the drug eluting membrane. To evaluate in vivo tumor growth inhibition activity, CT-26 bearing Balb/c nude mice were used. Results: PS was uniformly spread in the membrane. GEM was located in the nearby abluninal side of the membrane. The releasing of GEM was not influenced by the addition of PS. Also, under the light exposure, the singlet oxygen was generated by PS at the membrane surface for 2 weeks. The PE% of GEM from PS-GEM with light was 30% higher than the others of in vitro penetration test. To visualize the tissue penetration test of the hydrophilic molecule, the intensity of the penetrated FITC in the PS-fluorescein with light group increased by approximately 200% compared to the others. To evaluate the tumor growth inhibition efficiency, the tumor with GEM-PU with or without light and PS-GEM-PU without light grew exponentially; almost 3 times larger tumor volumes were measured than in the PS-GEM-PU group. In TUNEL assay, apoptotic cells were detected at the nearby tumor-membrane interface in the case of GEM-PU with or without light and PS-GEM-PU without light. Discussion: To improve the tissue penetration efficiency of hydrophilic-drugs in non-vascular drug eluting stents(DES), we designed photochemical tissue penetration invested DES. Consequentially, tumor growth, when implanted with PS-GEM-PU, was effectively inhibited without significant side effects. Based on these results, we believe that the photochemical tissue penetration-DES system has great potential for improving the therapeutic effect of conventional DES. Conclusion: PS-GEM-PU was designed and prepared to increase both the tissue penetration and the therapeutic efficacy of a GEM loaded DES. In this study, we overcame this barrier using a PS-DES membrane. Thus, the membrane has a higher therapeutic effect than a conventional GEM eluting membrane. To improve the therapeutic potency of PS-DES system, further experiments were required to optimize drug content in DES membrane.
机译:简介:非血管药物洗脱支架(DES)是一种生物医学设备,已植入胃肠道(GI),用于在由于肿瘤生长而出现阻塞性症状时稳定体液的流动。近来,由于GEM在GI肿瘤治疗中的强治疗作用,吉西他滨(GEM)洗脱膜覆盖的支架已得到开发和强调。然而,GEM由于其亲水性和上皮屏障功能而在GI道中具有低的组织穿透效率(PE%)。由于这个原因,经GEM治疗的肿瘤的某些细胞可以继续增殖并允许肿瘤生长。我们认为,改变上皮层对于改善药物渗透是必需的。材料和方法:为了制备膜,将200 mL上述混合溶液(吉西他滨(GEM),光敏剂(PS),聚氨酯(PU))倒入聚四氟乙烯(Teflon)模具中并干燥。用场发射扫描电子显微镜(FE-SEM)观察每个膜的表面形态。为了确认药物释放行为,将GEM-PU(无PS膜)和PS-GEM-PU放入锥形管中,并加入磷酸盐缓冲液。为了确认单线态氧的生成,将PS-GEM-PU在PBS中孵育0.1或2周。为了确认PE%增强机制,将CT-26细胞培养在6孔板中,并培养Chang细胞。为了可视化亲水分子的组织渗透,在药物洗脱膜中加载了荧光素而不是GEM。为了评估体内肿瘤生长抑制活性,使用了携带CT-26的Balb / c裸鼠。结果:PS均匀地分布在膜中。 GEM位于膜的近侧。 GEM的释放不受PS添加的影响。另外,在曝光下,通过PS在膜表面产生单线态氧2周。带有光的PS-GEM的GEM的PE%比体外渗透测试的高出30%。为了可视化亲水性分子的组织渗透测试,带有荧光基团的PS荧光素中渗透的FITC的强度比其他荧光剂增加了约200%。为了评估肿瘤生长抑制效率,具有或不具有光的GEM-PU和不具有光的PS-GEM-PU的肿瘤呈指数增长。测量的肿瘤体积是PS-GEM-PU组的近3倍。在TUNEL分析中,在有或没有光的GEM-PU和没有光的PS-GEM-PU的情况下,在附近的肿瘤-膜界面处检测到凋亡细胞。讨论:为了提高亲水性药物在非血管药物洗脱支架(DES)中的组织渗透效率,我们设计了光化学组织渗透投资的DES。因此,当植入PS-GEM-PU时,肿瘤的生长得到了有效的抑制,而没有明显的副作用。基于这些结果,我们相信光化学组织渗透-DES系统具有改善常规DES的治疗效果的巨大潜力。结论:PS-GEM-PU的设计和制备可以提高GEM载体DES的组织渗透性和治疗效果。在这项研究中,我们使用PS-DES膜克服了这一障碍。因此,该膜具有比常规GEM洗脱膜更高的治疗效果。为了提高PS-DES系统的治疗效力,还需要进一步的实验来优化DES膜中的药物含量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号